双分支的注意力融合网络用于肺炎检测
Tiezhu Li1, Bingbing Li1, Chao Zheng2
1Henan University, Computer and Information Engineering, Kaifeng, People's Republic of China.
Biomedical physics & engineering express
|July 4, 2025
概括
一个新的AI模型,双分支注意力融合网络 (D-BAFN),在胸部X射线中准确检测肺炎. 这种先进的深度学习方法可以改善早期诊断,从而改善患者的治疗结果.
科学领域:
- 医学成像和人工智能 医学成像和人工智能
- 计算机视觉在医疗保健中的应用
- 呼吸道疾病的诊断 呼吸道疾病的诊断
背景情况:
- 肺炎是一个重大的全球健康威胁,导致高发病率和死亡率,特别是在弱势群体中.
- 及时和精确的肺炎诊断对于有效的治疗和改善患者预后至关重要.
- 目前的诊断方法可能是有限的,需要先进的工具来提高准确性.
研究的目的:
- 引入一种新的深度学习模型,双分支注意力融合网络 (D-BAFN),用于从胸部X射线图像中改进肺炎分类.
- 为了利用转移学习和混合架构,将CNN和状态空间模型结合起来,以进行强大的特征提取.
- 通过适应性特征融合的注意力机制来提高诊断准确度.
主要方法:
- 开发了一个双分支注意力融合网络 (D-BAFN),集成ResNet-18和Mamba Vision进行特征提取.
- 采用自我注意力机制来融合特征,专注于胸部X射线中的关键病变区域.
- 通过广泛的数据增强和转移学习,对儿科和多源数据集进行实验.
主要成果:
- 在二元肺炎分类任务中,D-BAFN模型实现了97.78%的准确性.
- 在多类数据集 (肺炎,COVID-19,正常) 上,该模型达到97.20%的准确性,F1得分为0.972和AUC为0.997.
- 在多类分类中证明了高精度 (0.966) 和回忆 (0.978),表明了强大的性能.
结论:
- D-BAFN模型在将肺炎从胸部X射线分类方面显示出显著的有效性和稳定性.
- 这种人工智能驱动的方法在临床实践中为肺部疾病的早期和准确检测提供了一个有希望的工具.
- 这项研究强调了混合深度学习架构在推进医疗诊断方面的潜力.
相关概念视频
01:30Pneumonia I: Introduction
342
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
342
01:29Pneumonia II: Pathophysiology
594
The pathophysiology of pneumonia involves the following steps:
594
01:27Pneumothorax-II
382
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
382
01:30Pneumonia III: Complications and Assessment
452
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
452
01:21Acute Respiratory Failure-II
374
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
374
01:28Pneumonia IV: Management
455
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
455